Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus

被引:57
作者
Kyttaris, VC
Juang, YT
Tenbrock, K
Weinstein, A
Tsokos, GC
机构
[1] Walter Reed Army Inst Res, Dept Cellular Injury, Silver Spring, MD 20910 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA
[3] Washington Hosp Ctr, Rheumatol Sect, Dept Med, Washington, DC 20010 USA
[4] Univ Munster, Dept Pediat, D-4400 Munster, Germany
关键词
D O I
10.4049/jimmunol.173.5.3557
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells from patients with systemic lupus erythematosus express increased levels of the cAMP response element modulator (CREM) that has been shown to bind to the IL-2 promoter and suppress its activity. In this study, we demonstrate that CREM binds to the proximal promoter of the c-fos proto-oncogene in live systemic lupus erythematosus T cells and represses its expression following stimulation in vitro. Decreased levels of c-fos protein result in decreased AP-1 activity, as determined in shift assays. Blockade of the translation of CREM mRNA with an antisense CREM vector increases the expression of c-fos and the AP-1 activity. The levels of c-fos mRNA vary with disease activity. We conclude that CREM represses the expression of c-fos and limits the activity of the enhancer AP-1. Thus, CREM is involved indirectly in the modulation of transcriptional regulation of multiple genes including IL-2.
引用
收藏
页码:3557 / 3563
页数:7
相关论文
共 35 条
[1]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[2]   Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays [J].
Bustin, SA .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (02) :169-193
[3]   PROTOONCOGENE EXPRESSION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AS AN INDICATOR OF THE DISEASE-ACTIVITY [J].
DEGUCHI, Y ;
HARA, H ;
NEGORO, S ;
KAKUNAGA, T ;
KISHIMOTO, S .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 45 (03) :424-439
[4]   TRANSCRIPTIONAL ANTAGONIST CAMP-RESPONSIVE ELEMENT MODULATOR (CREM) DOWN-REGULATES C-FOS CAMP-INDUCED EXPRESSION [J].
FOULKES, NS ;
LAOIDE, BM ;
SCHLOTTER, F ;
SASSONECORSI, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5448-5452
[5]   Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand [J].
Georgescu, L ;
Vakkalanka, RK ;
Elkon, KB ;
Crow, MK .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2622-2633
[6]   AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis [J].
Han, ZN ;
Boyle, DL ;
Manning, AM ;
Firestein, GS .
AUTOIMMUNITY, 1998, 28 (04) :197-208
[7]   Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity [J].
Herndon, TM ;
Juang, YT ;
Solomou, EE ;
Rothwell, SW ;
Gourley, MF ;
Tsokos, GC .
CLINICAL IMMUNOLOGY, 2002, 103 (02) :145-153
[8]   P21waf1/cip1 is down-regulated in conjunction with up-regulation of c-Fos in the lymphocytes of rheumatoid arthritis patients [J].
Hikasa, M ;
Yamamoto, E ;
Kawasaki, H ;
Komai, K ;
Shiozawa, K ;
Hashiramoto, A ;
Miura, Y ;
Shiozawa, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 304 (01) :143-147
[9]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[10]   SERUM INTERLEUKIN-10 TITERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS REFLECT DISEASE-ACTIVITY [J].
HOUSSIAU, FA ;
LEFEBVRE, C ;
VANDENBERGHE, M ;
LAMBERT, M ;
DEVOGELAER, JP ;
RENAULD, JC .
LUPUS, 1995, 4 (05) :393-395